Feasibility and future directions of radiation-free retrograde intrarenal surgery
- PMID: 40226057
- PMCID: PMC11986464
- DOI: 10.21037/tau-2025-5
Feasibility and future directions of radiation-free retrograde intrarenal surgery
Keywords: As Low As Reasonably Achievable (ALARA); Retrograde intrarenal surgery (RIRS); radiation-free (RF); randomized clinical trial.
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-2025-5/coif). S.H. reports receiving consulting fees from Boston Scientific Japan, Olympus, Eisai, Ono pharmaceuticals, and MSD. T.Y. reports receiving consulting fees from Takeda pharmaceuticals, Boston Scientific Japan, Asuteras, Kissei Pharmacy, Kyorin Pharmacy, Janssen Pharma, Bayer, Merck Biopharma, Olympus, Eisai, Noippon-shinyaku, and MSD. The authors have no other conflicts of interest to declare.
Comment on
-
The Efficacy and Safety of Radiation-Free Retrograde Intrarenal Surgery: A Prospective Multicenter-Based, Randomized, Controlled Trial.J Urol. 2024 Jun;211(6):735-742. doi: 10.1097/JU.0000000000003920. Epub 2024 May 9. J Urol. 2024. PMID: 38721932 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials